NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.

Filter By:
Letter to Congressional Committee Leadership on Research and Innovation & Criminal Justice
Letter to House and Senate Appropriations Committee leadership requesting $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health and $1 million for the National Institute of Justice to conduct public health research into firearm morbidity and mortality prevention.
Letter to Congressional Leadership on Medicaid
Letter to Congressional leadership, urging protection of the Medicaid program from cuts or harmful changes in any budget negotiations or other legislative venue this year.
Statement on Medicaid
Statement urging Congress to reject adding a ‘work requirement’ policy to the Medicaid program.
Statement on Medication Access
Statement with patient advocacy organizations on the Alliance for Hippocratic Medicine et al v FDA et al ruling and implications for future access to FDA-approved drugs.
Letter to FDA Commissioner & HHS Secretary on Research and Treatment Innovation
Letter to HHS Secretary Becerra and FDA Commissioner Califf urging the Federal Drug Administration FDA to reissue its ban of electrical stimulation devices used to treat self-injurious or aggressive behavior.
Statement on Health Coverage
Statement in response to the ruling in the Braidwood versus Becerra case, which threatens coverage of U.S. Preventive Services Task Force recommended preventive services without cost sharing as required under the Affordable Care Act.
Letter to Congressional Committee Leadership on Mental Health Workforce
Letter to Senate HELP Committee leadership in response to the request for information (RFI) on the health care workforce shortage.
Letter to Members of Congress on Health Coverage
Letter to Members of Congress in opposition to S.184 and H.R. 277 - the Regulations from the Executive in Need of Scrutiny Act of 2023 (REINS Act).
Regulatory Comment to CMS Administrator & HHS Secretary on Health Coverage
Regulatory comments to HHS Secretary Becerra and CMS Administrator Brooks-LaSure in response to the Advancing Interoperability and Improving Prior Authorization Proposed Rule.
Statement on Medicaid
Statement in support of federal and state policies that ensure those who remain eligible for Medicaid and CHIP understand this process and successfully reenroll, while those who are no longer eligible transition to other forms of quality, affordable healthcare coverage.
Displaying results 11-20 (of 249)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >